The granules of mycobacteria, originally described by Robert Koch as spores, have been shown in a preceding communication to be sites of oxidative-reductive enzymatic activity. In respect to several enzymatic reactions, as well as in tinctorial and morphological characteristics, these mycobacterial granules were shown to correspond to mitochondria (Mudd, Winterscheid, DeLamater, and Henderson, 1951). In the present communication granules in several other species of bacteria have been examined by similar criteria. These granules also have been found to correspond in essential characteristics to mitochondria. METHODS AND MATERIALS The microorganisms used were: Escherichia coli, strain B; Bacillus megatherium, a strain originally given us by Dr. C. F. Robinow; Micrococcus cryophilus, a large gram-variable coccus isolated in the Department of Agriculture (McLean, Sulzbacher, and Mudd, 1951) and utilized for studies on nuclear mitosis (DeLamater and Woodburn, 1951); and Saccharomyces cerevisiae, a strain from baker's yeast and a "cytochromeless" variant, received through the courtesy of Dr. H. M. Davidson, which had been derived as described by Ephrussi and colleagues (Ephrussi, Hottinguer, and Chimenes, 1949; Slonimski and Ephrussi, 1949). The cells of E. coli and B. megatherium used had been grown for 3 to 4 hours at 37 C on Morton and Engley (1945) agar slants or in M. and E. broth. The micrococcus was incubated 24 hours at 20 C on similar agar slants or broth prior to use. Both strains of S. cerevisiae were incubated 24 hours at 37 C onSabouraud's agar slants. The reactions examined for were the reduction of 2,3,5-triphenyltetrazolium and neotetrazolium, probably indicating the action of flavoprotein enzymes, oxidation of the Nadi reagent, indicating cytochrome oxidase, staining with the mitochondrial stain Janus green B, the Baker acid-hematin stain for phospholipid, and the Harman mitochondrial stain. Experimental procedures were followed as in the preceding communication (Mudd, Winterscheid, DeLamater, and Henderson, 1951) with the following modifications: The reduction of triphenyltetrazolium and neotetrazolium was demonstrated I This research has been aided by a grant from the Damon Runyon Fund through the American Cancer Society as recommended by the Committee on Growth of the National Research Council.